Promising Results For Glivec In CML Continue, FDA Grants Priority Review
High Response Rate of Hairy Cell Leukemia Patients to Immunotoxin Treatment In Phase I
Wilms’ Tumor Survivors At High Risk Of Heart Failure
Cancer Pain Treatment Guide Published By NCCN, ACS
Without Advance Directives, Families Prolong Treatment
Long-Term Estrogen Use May Increase Ovarian Cancer Risk
Natural Substance Blocks Androgen Activity In Vitro
NCI-Approved Clinical Trials Listed For Month Of March
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - Brian Wolpin celebrates FDA approval of daraxonrasib in pancreatic cancer as the future of the field
- The end of “more money, more people, more trials”
Cancer centers are being asked to grow their portfolios on flat budgets. Headcount is the wrong answer. - Harold Freeman, a surgeon who championed health equity, dies at 93
Freeman, the father of patient navigation, served as president of ACS and chair of the President’s Cancer Panel - The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish
